Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
SolGel Technologies SLGL Stock Momentum Shift Insight Technical Weakness 20260418 MFA MFAN Stock Is It Safe Smart Money Outflows 20260415 Enphase Energy ENPH Stock Prediction Q4 2025 Profit Exceeds Views EDRY EuroDry notches 176 percent Q4 2025 EPS beat but shares slip 303 percent in todays trading Odysightai ODYS Stock Strategic Buy or Not Q2 2025 EPS Misses Estimates How Ziff Davis ZD performance compares to expectations Flirts with Breakout 20260511 Is First Bank FRBA stock respecting key technical levels Investors Pile In 20260420 Dingdong DDL Slips 367 Testing 238 Support 20260515 Megacap Tech IPOs Force Index Providers to Rethink Inclusion Rules Bill Ackmans Pershing Square Acquires Microsoft Stake Betting on AI and Cloud Expansion Yalla YALA Stock Analysis Climbs 320 Eyes on 711 20260518 Consumer Prices Surge 38 in April Marking Fastest Annual Inflation Since Mid2023 GrabAGun PEW Stock Down 177 Support Test at 264 20260518 Market Wrap Healthcare and Tech Lead as Broad Rally Pushes SP 500 to 7473 Susquehanna Adjusts Price Target for Power Integrations Signals Potential Upside Taiwan Chip Stocks Rally as Nvidias 150 Billion Spending Plan Signals Demand Boost Explainer How DualClass Shares Enable Founder Control at Meta and SpaceX Telecom CEO Warns Europe Remains Vulnerable to US Satellite and AI Dominance Microsofts New Responsible Tech Lead Navigates Tension Between AI Speed and Trustworthy Development DOO Q1 2026 Earnings Strong EPS Beat with 55 Surprise XBIO Q2 2025 Earnings Loss Narrows Despite No Revenue as Biotech Advances Pipeline SAN Q1 2026 Earnings EPS Beats Estimates by 31 Shares Rally Lantheus Holdings LNTH Q1 2026 Earnings EPS Surges Past Estimates as Radiopharmaceutical Momentum Continues SND Q1 2026 Earnings Loss Per Share of 010 Stock Declines 53 on Uncertain Outlook Cadrenal Therapeutics Q1 2026 Earnings Narrowed Loss Surpasses Estimates Stock Edges Higher Renasant Corporation RNST Gains 102 as Stock Approaches Key Resistance Zone CHS Inc CHSCM Holds Steady Near Support as Price Action Remains RangeBound Meritage Homes MTH Edges Higher Amid Housing Sector Resilience Jasper Therapeutics JSPR Hovers Near Support as Biotech Sentiment Remains Cautious Enbridge ENB Slips 105 as Energy Infrastructure Faces Headwinds